Perhaps, rather than fighting off cannabis, pharmaceutical companies can invest more into understanding the many possibilities and benefits of cannabis. Individual states continue to open their...
To think that Pharma doesn’t have a strategy against a plant that is costing them upwards to $10 billion of lost potential revenue is to be...
This is the first study to ever assess the impact of marijuana on the pharmaceutical industry, regardless of patient or product type. Each time a single...
Around 131 million people in the United States take prescription drugs. That translates to 66% of the population, most of whom belong to the elderly and those who have chronic illnesses....